Loading
Healthpeak Properties, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Thomas John T, was filed 06 Aug 2025.
Insider Decl.
584
Thresholds
n/a
Buy Volume
€3M
29 ops. · all time
Sell Volume
€6M
22 ops. · all time
Who traded when
BuySaleScott M. Brinker5 buys
John T. Thomas2 buys
Pamela Shelley-Kessler2 buys
Tommy G. Thompson2 buys
Ava Lias-Booker1 buy
Katherine M. Sandstrom1 buy
+2 other insiders
Since the insiders bought
- +26.2%Entry US$16.96 · Close at T+365 US$21.41
- +26.8%Entry US$17.19 · Close at T+365 US$21.79
- +9.3%Entry US$17.52 · Close at T+365 US$19.15
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Healthpeak Properties, Inc. Buy (bullish), based on 19 analysts. Average price target: US$22.61.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 15,302 of 26,192 companies
46.5
score / 100
Value50
Quality43
FCF yld9.6%
Earn yld0.5%
EV/EBITDA14.1x
ROE3.0%
Gross mgn60%
Net mgn2.5%
Debt/EBITDA6.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$18.41
Analyst consensus
19 analystsBuy
US$17.00Target US$22.61(+23%)US$29.00
Income statement
RevenueUS$2.8B
Gross profitUS$1.7B60% margin
EBITDAUS$1.6B58% margin
Net incomeUS$70.5M8.2% margin
Valuation
PER (trailing)52.6x
PER (forward)131.5x
P/Book1.6x
Beta0.99
Balance sheet & cash
Market capUS$13B
Total debtUS$10.1B
Free Cash FlowUS$1.3B
Debt / Equity109%
Profitability & ownership
ROE3.0%
ROA1.5%
% insiders0.3%
% institutions97.8%
Last declaration on 2 June 2026
Declarations584 total
1,347 shares@ US$15.46150.0002% mcap1.8% of flowCommon StockSEC:0001540329-26-000007:0
114 shares@ US$19.150.0000% mcap0.2% of flowCommon StockSEC:0001540329-26-000007:1
10,989 shares@ US$19.45040.0016% mcap79.0% of flowCommon StockSEC:0001908406-26-000004:0
495 shares@ US$16.705.0% of flowCommon StockSEC:0001792329-26-000006:0
808 shares@ US$16.708.1% of flowCommon StockSEC:0001792329-26-000006:1
6,454 shares@ US$16.8528.8% of flowCommon StockSEC:0001454164-26-000002:1
657 shares@ US$16.856.7% of flowCommon StockSEC:0001792329-26-000004:0
23,739 shares0Common StockSEC:0001454164-26-000002:0
3,828 shares0Common StockSEC:0001792329-26-000002:1
252 shares@ US$17.710.9% of flowCommon StockSEC:0001792329-26-000002:2
456 shares0Common StockSEC:0001792329-26-000002:0
58 shares@ US$18.260.7% of flowCommon StockSEC:0001950684-25-000003:1
140 shares@ US$18.260.0% of flowCommon StockSEC:0001540329-25-000003:1
81 shares@ US$18.260.4% of flowCommon StockSEC:0001454164-25-000003:1
55 shares@ US$18.267.7% of flowCommon StockSEC:0002054541-25-000004:1
115 shares@ US$18.261.5% of flowCommon StockSEC:0001963756-25-000003:1
92 shares@ US$18.260.1% of flowCommon StockSEC:0001585224-25-000003:1
338 shares@ US$14.79853.1% of flowCommon StockSEC:0001792329-25-000003:0
23 shares@ US$18.260.3% of flowCommon StockSEC:0001792329-25-000003:1
810 shares@ US$14.7985100.0% of flowCommon StockSEC:0002054541-25-000004:0
844 shares@ US$14.798517.9% of flowCommon StockSEC:0001950684-25-000003:0
1,689 shares@ US$14.798552.1% of flowCommon StockSEC:0001585224-25-000003:0
1,689 shares@ US$14.79852.2% of flowCommon StockSEC:0001540329-25-000003:0
1,448 shares@ US$14.79859.0% of flowCommon StockSEC:0001454164-25-000003:0
1,689 shares@ US$14.798531.8% of flowCommon StockSEC:0001963756-25-000003:0
25 of 584 declarations
About Healthpeak Properties, Inc.
At Healthpeak Properties, Inc., purchases outnumber sales: 29 purchases worth EUR 3.5 million (median EUR 78,275) against 22 sales worth EUR 5.6 million (median EUR 76,799), or 57% purchases among open-market trades. The largest is Lauralee Martin's, then President and CEO: EUR 562,758 on February 11, 2016. R. Kent Griffin Jr. (Director) bought EUR 420,897 on May 14, 2018, Scott M. Brinker (President and CEO) EUR 361,019 on March 2, 2023. From April 28, 2025 to May 28, 2025, 7 filers bought EUR 850,531, and 20 filings are marked as clustered.
The sales concentrate on Thomas Klaritch, filed in turn as EVP and COO, EVP, CDO and COO, then Senior Managing Director: EUR 2,144,913 on December 4, 2018, EUR 1,142,916 on September 4, 2019 and EUR 589,353 on September 6, 2016. Klaritch is also the most frequent filer with 60 filings.
Read moreShow less
584 filings from January 4, 2016 to June 2, 2026, 463 of them grants, with 84 in 2016 and 22 in 2024. Christine Garvey (Director) signs 53, Thomas M. Herzog (CEO) 46. The US real estate company is worth USD 13.05 billion. Last twelve months: 25 filings, 1 sale, no purchase. For the 29 purchases with a result, the 90-day median is 2.2%, with 59% of results positive (recorded past, not a forecast).
